HK
GSK icon

Horizon Kinetics’s GSK GSK Stock Holding History

Horizon Kinetics’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$933K Hold
19,538
– – 0.03% 169
2018
Q3 		$981K Hold
19,538
– – 0.02% 185
2018
Q2 		$985K Hold
19,538
– – 0.03% 176
2018
Q1 		$954K Buy
19,538
+200
+1% +$9.31K 0.03% 183
2017
Q4 		$857K Sell
19,338
-1,442
-7% -$66.6K 0.03% 203
2017
Q3 		$1.05M Buy
20,780
+1,522
+8% +$77.2K 0.03% 183
2017
Q2 		$1.04M Hold
19,258
– – 0.03% 191
2017
Q1 		$1.01M Buy
19,258
+80
+0.4% +$4.06K 0.03% 190
2016
Q4 		$923K Sell
19,178
-1,600
-8% -$79K 0.03% 201
2016
Q3 		$1.12M Hold
20,778
– – 0.03% 183
2016
Q2 		$1.13M Hold
20,778
– – 0.03% 187
2016
Q1 		$1.05M Sell
20,778
-300
-1% -$14.9K 0.03% 191
2015
Q4 		$1.06M Buy
21,078
+500
+2% +$25.5K 0.02% 186
2015
Q3 		$989K Buy
20,578
+1,520
+8% +$79.1K 0.02% 197
2015
Q2 		$992K Buy
19,058
+40
+0.2% +$2.25K 0.01% 233
2015
Q1 		$1.1M Buy
19,018
+40
+0.2% +$2.29K 0.02% 225
2014
Q4 		$1.01M Sell
18,978
-240
-1% -$13.4K 0.01% 238
2014
Q3 		$1.1M Buy
19,218
+24
+0.1% +$1.47K 0.01% 224
2014
Q2 		$1.28M Buy
19,194
+160
+0.8% +$10.8K 0.02% 215
2014
Q1 		$1.27M Buy
19,034
+56
+0.3% +$3.79K 0.02% 213
2013
Q4 		$1.27M Hold
18,978
– – 0.02% 219
2013
Q3 		$1.19M Buy
18,978
+840
+5% +$54.1K 0.02% 217
2013
Q2 		$1.13M Buy
+18,138
New +$1.15M 0.02% 230

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Horizon Kinetics's GSK Position: Q4 2018 in Review

Horizon Kinetics held its GSK (GSK) position steady in Q4 2018 at 19,538 shares worth $933K. The position accounts for 0.03% of the portfolio, ranked #169.

Horizon Kinetics first reported a position in GSK in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.28M in Q2 2014. 800 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Horizon Kinetics held 19,538 shares of GSK worth $933K as of Q4 2018.
  • Horizon Kinetics left its GSK share count unchanged in Q4 2018.
  • GSK made up 0.03% of Horizon Kinetics's portfolio in Q4 2018, its #169 holding.
  • Horizon Kinetics first reported a position in GSK in Q2 2013 and has held it in 23 quarters since.
  • Horizon Kinetics's GSK position peaked at $1.28M in Q2 2014.
  • 800 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.